These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18318128)

  • 1. [Mutations of the Epstein-Barr virus LMP1 gene mutations in Russian patients with lymphoid pathology and healthy individuals].
    Pavlish OA; Diduk SV; Smirnova KV; Shcherbak LN; Goncharova EV; Shalginskikh NA; Arkhipov VV; Kichigina MIu; Stepina VN; Belousova NV; Osmanov EA; Iakovleva LS; Gurtsevich VE
    Vopr Virusol; 2008; 53(1):10-6. PubMed ID: 18318128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epstein-Barr Virus LMP1 oncogene variants in cell lines of different origin].
    Yakovleva LS; Senyuta NB; Goncharova EV; Scherback LN; Smirnova RV; Pavlish OA; Gurtsevitch VE
    Mol Biol (Mosk); 2015; 49(5):800-10. PubMed ID: 26510598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural variability of the carboxy-terminus of Epstein-Barr virus encoded latent membrane protein 1 gene in Hodgkin's lymphomas.
    Guiretti DM; Chabay PA; Valva P; Stefanoff CG; Barros MH; De Matteo E; Renault IZ; Preciado MV; Hassan R
    J Med Virol; 2007 Nov; 79(11):1730-22. PubMed ID: 17854036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [C-terminal 30 bp-deletion mutation of latent membrane protein 1 gene of Epstein-barr virus in non-hodgkin's lymphoma].
    Liu JR; Lin Q; Wu XY
    Ai Zheng; 2005 Feb; 24(2):145-8. PubMed ID: 15694022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina.
    Chabay P; De Matteo E; Merediz A; Preciado MV
    Arch Virol; 2004 Aug; 149(8):1515-26. PubMed ID: 15290377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LMP1 promoter sequence analysis in Epstein Barr virus pediatric infection reveals preferential circulation of B95.8 related variants in Argentina.
    Gantuz M; Lorenzetti MA; Altcheh J; De Matteo E; Moscatelli G; Moroni S; Chabay PA; Preciado MV
    Infect Genet Evol; 2013 Mar; 14():275-81. PubMed ID: 23305886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ancient variants of the Epstein-Barr virus (Herpesviridae, Lymphocryptovirus, HHV-4): hypotheses and facts.].
    Smirnova KV; Senyuta NB; Lubenskaya AK; Dushenkina TE; Gurtsevich VE
    Vopr Virusol; 2020; 65(2):77-86. PubMed ID: 32515563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STRUCTURAL AND FUNCTIONAL CHARACT ERISTICS OF THE LMP1 ONCOGENE IN PATIENTS WITH TUMORS ASSOCIATED AND NOT ASSOCIATED WITH THE EPSTEIN-BARR VIRUS.
    Senyuta NB; Smirnova KV; Diduk SV; Goncharova EV; Shcherbak LN; Gurtsevitch VE
    Mol Gen Mikrobiol Virusol; 2016 Sep; 34(2):71-75. PubMed ID: 30380210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of LMP1 variants of EBV in Southern Thailand: evidence for strain-associated T-cell tropism and pathogenicity.
    Saechan V; Mori A; Mitarnun W; Settheetham-Ishida W; Ishida T
    J Clin Virol; 2006 Jun; 36(2):119-25. PubMed ID: 16616610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Functional analysis of Epstein-Barr virus latent membrane proteins (LMP1) in patients with limphoproliferative disorders].
    Smirnova KV; Diduk SV; Gurtsevich VÉ
    Biomed Khim; 2011; 57(1):114-26. PubMed ID: 21516783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epstein-Barr virus (EBV) in Russia: infection of the population and analysis of the LMP1 gene variants in patients with EBV-associated pathologies and healthy individuals].
    Goncharova EV; Senyuta NB; Smirnova KV; Shcherbak LN; Gurtsevich VE
    Vopr Virusol; 2015; 60(2):11-7. PubMed ID: 26182651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A deletion mutant of the LMP1 oncogene of Epstein-Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma.
    Knecht H; Martius F; Bachmann E; Hoffman T; Zimmermann DR; Rothenberger S; Sandvej K; Wegmann W; Hurwitz N; Odermatt BF
    Leukemia; 1995 Mar; 9(3):458-65. PubMed ID: 7885044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleotide sequences and functions of the Epstein-Barr virus latent membrane protein 1 genes isolated from salivary gland lymphoepithelial carcinomas.
    Jen KY; Higuchi M; Cheng J; Li J; Wu LY; Li YF; Lin HL; Chen Z; Gurtsevitch V; Fujii M; Saku T
    Virus Genes; 2005 Mar; 30(2):223-35. PubMed ID: 15744579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinctive Epstein-Barr virus variants associated with benign and malignant pediatric pathologies: LMP1 sequence characterization and linkage with other viral gene polymorphisms.
    Lorenzetti MA; Gantuz M; Altcheh J; De Matteo E; Chabay PA; Preciado MV
    J Clin Microbiol; 2012 Mar; 50(3):609-18. PubMed ID: 22205789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and analysis of two strongly transforming isoforms of the Epstein-Barr-Virus(EBV)-encoded latent membrane protein-1 (LMP1) from a single Hodgkin's lymphoma.
    Mehl AM; Fischer N; Rowe M; Hartmann F; Daus H; Trümper L; Pfreundschuh M; Müller-Lantzsch N; Grässer FA
    Int J Cancer; 1998 Apr; 76(2):194-200. PubMed ID: 9537580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geographic sequence variation of latent membrane protein 1 gene of Epstein-Barr virus in Hodgkin's lymphomas.
    Lin JC; Lin SC; Luppi M; Torelli G; Mar EC
    J Med Virol; 1995 Feb; 45(2):183-91. PubMed ID: 7775937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP-1) gene and promoter in Hodgkin's disease isolates: selection against EBV variants with mutations in the LMP-1 promoter ATF-1/CREB-1 binding site.
    Sandvej K; Andresen BS; Zhou XG; Gregersen N; Hamilton-Dutoit S
    Mol Pathol; 2000 Oct; 53(5):280-8. PubMed ID: 11091852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [LMP1 gene variants of Epstein-Barr virus in patients with some lymphoproliferative malignancies].
    Gurtsevich VE; Goncharova EV; Shcherbak LN; Kovrigina AM; Falaleeva NA; Iakovleva LS; Stepina VN; Popova AA; Sterlikova AA; Osmanov EA; Pavlish OA
    Vopr Virusol; 2006; 51(2):35-9. PubMed ID: 16756177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
    Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM
    J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders.
    Smir BN; Hauke RJ; Bierman PJ; Gross TG; d'Amore F; Anderson JR; Greiner TC
    Lab Invest; 1996 Oct; 75(4):575-88. PubMed ID: 8874388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.